Here is how Annaly Capital Management (NLY) and Amerisafe (AMSF) have performed compared to their sector so far this year.

Here is how Atlanta Braves Holdings, Inc. (BATRA) and Atlanta Braves Holdings (BATRK) have performed compared to their sector so far this year.

Here is how CrossAmerica Partners (CAPL) and Delek Logistics Partners, L.P. (DKL) have performed compared to their sector so far this year.

Shares of C, BAC, MS, GS and WFC took a heavy hit on Thursday's trading session after Trump announced sweeping tariffs, raising recession risks.

After KO hits a 52-week high, we assess whether the current level warrants an opportunity to accumulate shares, hold positions or book profits.

Tom Forte, Maxim Group analyst, joins CNBC's 'Squawk on the Street' to discuss outlooks on how the tech sector is getting hit by tariffs, how Apple might shift it's production or move prices, and more.

SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- A second class action lawsuit has been filed against Atkore Inc. (NYSE: ATKR), a prominent manufacturer of electrical products, which include metal electrical conduit and fittings, plastic pipe conduit and fittings, electrical cable and flexible conduit, and international cable management systems. The second suit, captioned Coles, II v. Atkore Inc., et al., No. 1:25-cv-02686 (N.D. Ill.), seeks to represent investors who purchased or acquired Atkore common stock during an expanded class period – namely, between August 2, 2022 and February 3, 2025.

SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Semtech Corporation (NASDAQ: SMTC), a prominent high-performance, semiconductor, Internet of Things systems and cloud connectivity service provider, alleging that the company misled investors about the suitability of- and the ramp-up schedule for- its CopperEdge product portfolio. The suit, captioned Kleovoulos v. Semtech Corporation, et al., No. 2:25-cv-01474 (C.D. Cal.), represents investors who purchased or acquired Semtech securities between August 27, 2024 and February 7, 2025.

TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, Chairman, Michael Young, today provides shareholders with a update on its SRx Health Solutions, Inc. (“SRx Health”) acquisition and comments on SRx Health's recent debt-to-equity transaction.

The one event that strikes true fear into the heart of real estate investment trust (REIT) investors is the tenant default.

The same playbook on Friday has been seen, where traders simply sell everything they can as the global tariff war is expanding. At this point, the markets are simply in freefall.

Cash is becoming increasingly attractive due to negative equity risk premiums, widening credit spreads, making highly liquid instruments appealing. BIL ETF, with a 0.13% expense ratio and 4.31% yield to maturity, offers a stable, cash-like investment with minimal bid/ask spread. T-bills, once overlooked, might be the “lesser evil” in the market due to economic uncertainties, negative S&P 500 ERP, and risks in long-duration bonds.

TMDX Investors with Losses Encouraged to Contact the Firm Before Apr. 15th Deadline TMDX Investors with Losses Encouraged to Contact the Firm Before Apr. 15th Deadline

Stellantis NV said on Thursday it was temporarily laying off 900 workers at five U.S. facilities and pausing production at one assembly plant each in Mexico and Canada, after U.S. President Donald Trump's tariffs were announced.

WSFS (WSFS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

HomeTrust Bancshares (HTB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Pacira doses the first patient in the phase II ASCEND study of PCRX-201 gene therapy for OA of the knee.

Stocks like TAP, FMS, TGI and THG are seeing price strength and have a high chance of carrying the momentum forward.

Investors need to pay close attention to Leidos (LDOS) stock based on the movements in the options market lately.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.